Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022)
Tilray Brands' (TLRY) quarterly Depreciation & Amortization (CF) came in at $34.1 million in Q3 2022, down 13.38% YoY from $39.3 million in Q3 2021, and down 16.43% on a QoQ basis from $40.8 million in Q2 2022.
Tilray Brands (TLRY) Depreciation & Amortization (CF) (2017 - 2022) Analysis & Trends
Tilray Brands (TLRY) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $34.1 million in Q3 2022.
- Quarterly Depreciation & Amortization (CF) fell 13.38% year-over-year to $34.1 million in Q3 2022, while the trailing twelve-month figure through May 2023 was $34.1 million (down 77.96% YoY) and the FY2022 annual result came in at $154.6 million, up 127.9% from the prior year.
- Depreciation & Amortization (CF) declined to $34.1 million in Q3 2022, from $40.8 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $40.8 million in Q2 2022 to a low of $479000.0 in Q1 2018.
- A 5-year average of $16.7 million and a median of $11.5 million in 2020 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2018 — Depreciation & Amortization (CF) jumped 552.55% — and 2022, when it declined 13.38%.
- Tracing TLRY's Depreciation & Amortization (CF) over 5 years: stood at $2.9 million in 2018, then soared by 113.35% to $6.3 million in 2019, then soared by 91.61% to $12.0 million in 2020, then jumped by 211.45% to $37.5 million in 2021, then slipped by 9.08% to $34.1 million in 2022.
- The last three Depreciation & Amortization (CF) figures came in at $34.1 million (Q3 2022), $40.8 million (Q2 2022), and $37.0 million (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Tilray Brands | 523.93 Mn | 289.30 Mn | 90.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Aug 31, 2022 | 34.07 Mn |
| Aug 31, 2022 | 34.07 Mn |
| May 31, 2022 | 40.77 Mn |
| May 31, 2022 | 40.77 Mn |
| Feb 28, 2022 | 37.02 Mn |
| Feb 28, 2022 | 37.02 Mn |
| Nov 30, 2021 | 37.47 Mn |
| Nov 30, 2021 | 37.47 Mn |
| Aug 31, 2021 | 39.33 Mn |
| Aug 31, 2021 | 39.33 Mn |
| May 31, 2021 | 24.54 Mn |
| May 31, 2021 | 24.54 Mn |
| Nov 30, 2020 | 12.03 Mn |
| Nov 30, 2020 | 12.03 Mn |
| Aug 31, 2020 | 10.98 Mn |
| Aug 31, 2020 | 10.98 Mn |
| May 31, 2020 | 25.21 Mn |
| May 31, 2020 | 25.21 Mn |
| Mar 31, 2020 | 4.56 Mn |
| Mar 31, 2020 | 4.56 Mn |